Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Yokoyama

Showing results (301-310 of 310) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 310 results.
Clinical and Experimental Nephrology|August 29, 2020
Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemiaTakashi Wada, Akinori Hara, Eri Muso, et al.
Scientific Reports|June 13, 2022
Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort studyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Journal of Nephrology|April 2, 2022
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort StudyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Blood Purification|December 15, 2022
Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and HypercholesterolemiaAkinori Hara, Takashi Wada, Eri Muso, et al.
Clinical and Experimental Nephrology|October 12, 2012
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR)Hitoshi Yokoyama, Hitoshi Sugiyama, Hiroshi Sato, et al.
Clinical and Experimental Nephrology|August 12, 2022
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)Tomonori Kimura, Ryohei Yamamoto, Mitsuaki Yoshino, et al.
Clinical and Experimental Nephrology|April 22, 2018
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort studyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Clinical and Experimental Nephrology|March 9, 2020
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Clinical and Experimental Nephrology|June 21, 2020
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai, et al.
NPJ Digital Medicine|November 23, 2025
Domain-adaptive semi-supervised learning for efficient rare pathological lesion detection with minimal annotationIsao Matsui, Ayumi Matsumoto, Atsuhiro Imai, et al.
Pageof 31

Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
Clinical and Experimental Nephrology|August 29, 2020
Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemiaTakashi Wada, Akinori Hara, Eri Muso, et al.
Scientific Reports|June 13, 2022
Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort studyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Journal of Nephrology|April 2, 2022
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort StudyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Blood Purification|December 15, 2022
Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and HypercholesterolemiaAkinori Hara, Takashi Wada, Eri Muso, et al.
Clinical and Experimental Nephrology|October 12, 2012
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR)Hitoshi Yokoyama, Hitoshi Sugiyama, Hiroshi Sato, et al.
Clinical and Experimental Nephrology|August 12, 2022
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)Tomonori Kimura, Ryohei Yamamoto, Mitsuaki Yoshino, et al.
Clinical and Experimental Nephrology|April 22, 2018
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort studyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Clinical and Experimental Nephrology|March 9, 2020
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Clinical and Experimental Nephrology|June 21, 2020
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai, et al.
NPJ Digital Medicine|November 23, 2025
Domain-adaptive semi-supervised learning for efficient rare pathological lesion detection with minimal annotationIsao Matsui, Ayumi Matsumoto, Atsuhiro Imai, et al.
Pageof 31